Background Acute meningitis has a high case-fatality rate and survivors can have severe lifelong disability. We aimed to provide a comprehensive assessment of the levels and trends of global meningitis burden that could help to guide introduction, continuation, and ongoing development of vaccines and treatment programmes.AA received funding from Department of Science and
Technology, Government of India, New Delhi, through INSPIRE
Faculty Award Scheme. HB was financially supported by Mazandaran
University of Medical Sciences, Sari, Iran. AB received support for
research from the Project of Ministry of Education, Science and
Technology of the Republic of Serbia (No. III45005). TWB was
supported by the Alexander von Humboldt Foundation through the
Alexander von Humboldt Professor award, funded by the Federal
Ministry of Education and Research. FC reports European Union
(FEDER funds POCI/01/0145/FEDER/007728 and POCI/01/0145/
FEDER/007265) and National Funds (FCT/MEC, Fundação para a
Ciência e a Tecnologia and Ministério da Educação e Ciência) under the
Partnership Agreements PT2020 UID/MULTI/04378/2013 and PT2020
UID/QUI/50006/2013. HF was financially supported by Urmia
University of Medical sciences, Urmia, Iran. EF reports European
Union (FEDER funds POCI/01/0145/FEDER/007728 and
POCI/01/0145/FEDER/007265) and National Funds (FCT/MEC,
Fundação para a Ciência e a Tecnologia and Ministério da Educação e
Ciência) under the Partnership Agreements
PT2020 UID/MULTI/04378/2013 and PT2020 UID/QUI/50006/2013.
JK has received research funding from Merck Pharmaceuticals. AM
acknowledges that Imperial College London is grateful for support
from the NW London National Institute of Health and Research
Collaboration for Leadership in Applied Health Research and Care.
UOM acknowledges funding from the German National Cohort Study
Federal Ministry of Education and Research Grant #01ER1511/D. AMS
was supported by a fellowship from the Egyptian Fulbright Mission
Program. MSM acknowledges the support from the Ministry of
Education, Science and Technological Development, Republic of Serbia
(Contract No. 175087). KBT acknowledges funding supports from the
Maurice Wilkins Centre for Biodiscovery, Cancer Society of New
Zealand, Health Research Council, Gut Cancer Foundation, and the
University of Auckland. CSW’s work is funded by the South African
Medical Research Council and the National Research Foundation of
South Africa (Grant Numbers: 106035 and 108571)
